|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| HIV Infections | |||||
| Herpes Genitalis | |||||
| Venereal Diseases | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Acquired Immunodeficiency Syndrome | |||||
| Communicable Diseases | |||||
| Sexually Transmitted Diseases | |||||
| 3 | More general conditions related to this trial | ||||
| DNA Virus Infections | |||||
| Genital Diseases, Female | |||||
| Genital Diseases, Male | |||||
| Herpes Simplex | |||||
| Herpesviridae Infections | |||||
| Immune System Diseases | |||||
| Immunologic Deficiency Syndromes | |||||
| Infection | |||||
| Lentivirus Infections | |||||
| Retroviridae Infections | |||||
| RNA Virus Infections | |||||
| Sexually Transmitted Diseases, Viral | |||||
| Slow Virus Diseases | |||||
| Virus Diseases | |||||
| 4 | Interventions listed in this trial | ||||
| Male Circumcision | |||||
| 5 | Sponsors listed in this trial | ||||
| French National Agency for Research on AIDS and Viral Hepatitis | |||||